Search

Sitting Down With… Richard M. Johnson, President, and Chief Executive Officer, Parenteral Drug Association.

Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery.

The use of synthetic oligonucleotide therapeutics continues to grow because of their effectiveness in the treatment of devastating diseases.

Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV), lentiviral vectors and CAR-T immunotherapies.

Why drug developers should take a fresh look at long-acting dosage forms.

SCHOTT introduces an online shop with low minimum order quantities to overcome the challenges associated with conventional purchase order procedures.

Analytical Method Lifecycle Management (AMLM) principles require a holistic perspective where method robustness is considered together with process and product variability.

Out of trend (OOT) and out of specification (OOS) results for Microbiology testing are inevitable challenges that every sterile manufacturing environment must face.

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Finding new uses for old drugs is now a significant trend in the pharmaceutical and biotechnology industry.